Inventor
LIANG LINDA
US21 patents
⚠️ This page may combine multiple inventors who share the name “LIANG LINDA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
12 patentsUS10188730B2Jan 29, 2019
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME42 citations97
US10550190B2Feb 4, 2020
Phosphate based linkers for intracellular delivery of drug conjugates
MERCK SHARP & DOHME13 citations83
US10766957B2Sep 8, 2020
Anti-TIGIT antibodies
MERCK SHARP & DOHME7 citations82
US10618958B2Apr 14, 2020
Anti-TIGIT antibodies
MERCK SHARP & DOHME10 citations81
US9709568B2Jul 18, 2017
Antibodies that bind to human programmed death ligand 1 (PD-L1)
MERCK SHARP & DOHME14 citations79
US11278620B2Mar 22, 2022
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME3 citations72
US10898571B2Jan 26, 2021
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME2 citations72
US11510993B2Nov 29, 2022
Antibody drug conjugate for anti-inflammatory applications
MERCK SHARP & DOHME3 citations71
US10647771B2May 12, 2020
Antibody that binds to human programmed death ligand 2 (PD-L2) and uses thereof
MERCK SHARP & DOHME4 citations64
US11207406B2Dec 28, 2021
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME0 citations62
US11045547B2Jun 29, 2021
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME0 citations62
US9535074B2Jan 3, 2017
Immunoassay for soluble PD-L1
MERCK SHARP & DOHME1 citations40
MERCK SHARP & DOHME LLC
3 patentsPIONYR IMMUNOTHERAPEUTICS INC
3 patentsUS12065491B2Aug 20, 2024
Anti-TREM1 antibodies and related methods
PIONYR IMMUNOTHERAPEUTICS INC0 citations57
US11572407B2Feb 7, 2023
Anti-MARCO antibodies and uses thereof
PIONYR IMMUNOTHERAPEUTICS INC0 citations55
US10836828B2Nov 17, 2020
Anti-TREM1 antibodies and related methods
PIONYR IMMUNOTHERAPEUTICS INC0 citations47